2003
DOI: 10.1378/chest.123.1.187
|View full text |Cite
|
Sign up to set email alerts
|

Improved Myocardial Function Using a Na+/H+ Exchanger Inhibitor During Cardioplegic Arrest and Cardiopulmonary Bypass

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2004
2004
2020
2020

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 24 publications
0
5
0
Order By: Relevance
“…NHE1 is a key component of the heart's response to intracellular acidosis following ischemic insult. NHE1 activation during reperfusion is clearly detrimental to the heart, and the inhibition of this exchanger before reperfusion could reduce the associated myocardial damage (Cox et al, 2003;Garciarena et al, 2008). Our data showed that the expression of NHE1 protein was dramatically decreased in cardiac ischemia (Supplementary Figure S15).…”
Section: Discussionmentioning
confidence: 67%
“…NHE1 is a key component of the heart's response to intracellular acidosis following ischemic insult. NHE1 activation during reperfusion is clearly detrimental to the heart, and the inhibition of this exchanger before reperfusion could reduce the associated myocardial damage (Cox et al, 2003;Garciarena et al, 2008). Our data showed that the expression of NHE1 protein was dramatically decreased in cardiac ischemia (Supplementary Figure S15).…”
Section: Discussionmentioning
confidence: 67%
“…In clinical situations, tissue edema in the periinfarct zone is usually related to reversible ischemic injury. It has been well demonstrated that the dysfunction of the ion pumps and channels on the cell membranes is the principal mechanism of the ischemia‐associated myocardial edema (28–30). Water accumulation in the intracellular compartment seems to be a key component of ischemia‐induced edema.…”
Section: Discussionmentioning
confidence: 99%
“…These data suggest that Na ϩ accumulation by the cardiac myocyte likely initiated a cellular signaling cascade that perhaps includes increased myocyte inflammation, as indicated by increased myocyte secretion of TNF-␣, IL-1␤, and IL-6, culminating in myocardial contractile depression. Pharmacological interventions that limit the rise in intracellular Na ϩ have been shown to reduce myocardial injury and improve myocardial performance in several experimental models (12,26,37,43). Since the Na-K-ATPase exchanger is the primary regulator of sodium efflux from the cell, a pharmacological agent that increases Na-K-ATPase activity should promote Na ϩ efflux from the cell, limit injury-related Na ϩ accumulation, and provide organ protection (13).…”
Section: Discussionmentioning
confidence: 99%